Researchers at Oxford University have paused a small pediatric clinical trial of the coronavirus vaccine it is developing with AstraZeneca.
In a statement, the university said it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA).
An Oxford spokesperson said there are no safety concerns concerning the pediatric research, but the trial is paused while they await "additional information" from MHRA, which is reviewing possible links between the vaccine and rare blood clots in adults.
The trial is testing the effectiveness of the vaccine in up to 300 children between the ages of 6 and 17.
"Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial," the university said.
